Lawsuits have been filed against the maker of the Stryker LFIT V40 femoral head, alleging patients were harmed by use of the hip implant component. Issues associated with the Stryker LFIT V40 femoral head reportedly result in failure of the device requiring patients to undergo revision surgery to fix the problem. The Stryker LFIT V40 femoral head is used in the Stryker Accolade TMZF and Accolade 2, and the Citation and Meridian stems. Similar to issues with other metal-on-metal hip replacement devices, the Stryker LFIT reportedly has an increased risk of metallosis, which occurs when cobalt and chromium from the replacement device are absorbed by the tissue surrounding the implant and enter the patient’s blood stream. But the LFIT allegedly has another serious issue: an increased risk of spontaneous dislocation or dissociation. Health Canada has issued a recall on certain units of the devices, (8/24/16) but the US Food and Drug Administration has not done so. In issuing its recall, Health Canada noted Stryker had “received higher than expected complaints of taper lock failure for specific lots of certain sizes of LFIT Anatomic COCR V40TM Femoral Heads manufactured prior to 2011.”
Patients who suffer spontaneous dislocation or dissociation of the device, or who develop metallosis or other health problems as a result of the Stryker LFIT device may require painful revision surgery to replace their hip implant.
If you or somebody you know has suffered with these serious complications, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact Jamie Sheller Esq. at (800) 883-2299.